The pathological diagnosis based on the 5th edition of World Health Organization classification of Central Nervous System tumors was glioblastoma isocitrate dehydrogenase (IDH)–wild type, grade 2 oligodendroglioma, grade 3 astrocytoma IDH-mutant, and brain metastasis. Here, IDH3A is linked to central nervous system cancer.